<div dir="ltr">1. HEFCE requires immediate deposit (not immediate OA). so it is not in conflict with <i>Nature&#39;s</i> &amp; <i>Science&#39;s</i> PR practices. (<a href="http://www.sherpa.ac.uk/romeo/search.php?jtitle=nature&amp;issn=0028-0836&amp;zetocpub=Nature+Publishing+Group&amp;romeopub=Nature+Publishing+Group&amp;fIDnum=|&amp;mode=simple&amp;la=en&amp;version=&amp;source=journal&amp;sourceid=4008">N has a 6-month embargo</a> on OA; <a href="http://www.sherpa.ac.uk/romeo/search.php?jtitle=science&amp;issn=0036-8075&amp;zetocpub=American+Association+for+the+Advancement+of+Science&amp;romeopub=American+Association+for+the+Advancement+of+Science&amp;fIDnum=|&amp;mode=simple&amp;la=en&amp;version=&amp;source=journal&amp;sourceid=11114">S has none</a>.)<div><br></div><div>2. In any case, the 3-month grace-period would have been plenty of time for N &amp; S to do their PR even if the HEFCE rule had been immediate OA (which it is not).</div><div><br></div><div>3. This &quot;<a href="http://cogprints.org/1703/">Ingelfinger Rule</a>&quot; (designed to enhance paid circulation, not to enhance access) is a rule better honored in the breach: Very, very little good scholarship or science is done via PR rather than substance, especially in the online era.</div><div><br></div><div>SH<br><div class="gmail_extra"><br><div class="gmail_quote">On Thu, Nov 26, 2015 at 8:20 AM, Clement-Stoneham Geraldine <span dir="ltr">&lt;<a href="mailto:GERALDINE.CLEMENT-STONEHAM@headoffice.mrc.ac.uk" target="_blank">GERALDINE.CLEMENT-STONEHAM@headoffice.mrc.ac.uk</a>&gt;</span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div lang="EN-GB" link="blue" vlink="purple"><div><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">Danny, <u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">Some journals like to control the way information is being published about new papers, and therefore impose a strict press embargo period (another embargo, nothing to do with green OA embargo period). This sometime referred to as the “Ingelfinger rule” (<a href="https://en.wikipedia.org/wiki/Ingelfinger_rule" target="_blank">https://en.wikipedia.org/wiki/Ingelfinger_rule</a>).<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">All of this is well orchestrated, with a press pack made available so that coverage is reflecting accurately the research, and is advertised to authors as the added value offered by the publishers if they chose to submit their paper to them. This explains why you often see papers published in Nature, or Science, all making the headlines of daily press on the same day. The downside of course is that they do act as “gagging orders”, which can make it tricky for researchers to talk about their research once the paper has been accepted, but not yet published (which can go for weeks/months).<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">One of the issues with the HEFCE requirement to add article metadata to a repository at the acceptance stage, was that this could inadvertently breach such publishers’ embargo by release some (even if not much) information about the paper ahead of time. I believe this is what your researcher is concerned about. I am not sure that at this stage there is a way around it, but it would deserve a wider conversation. Less traditional journals such as eLife have deliberately done away with such embargo, and indeed encourage authors to discuss their research as soon as they wish, which seems to be better aligned with “open science” principles.<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">You’ll find more details for the journal you named here<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><a href="http://www.nature.com/authors/policies/embargo.html" target="_blank">http://www.nature.com/authors/policies/embargo.html</a><u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><a href="http://www.nejm.org/page/author-center/embargo" target="_blank">http://www.nejm.org/page/author-center/embargo</a><u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><a href="http://www.cell.com/cell/authors#prepub" target="_blank">http://www.cell.com/cell/authors#prepub</a><u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">and eLife’s policy<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><a href="http://elifesciences.org/elife-news/authors-the-media-and-elife" target="_blank">http://elifesciences.org/elife-news/authors-the-media-and-elife</a><u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">Best wishes<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;">Geraldine<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;"><u></u> <u></u></span></p><p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">Geraldine Clement-Stoneham<u></u><u></u></span></b></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">Knowledge and Information Manager<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">Medical Research Council<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">Tel: +44 </span><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">(0) 207 395 2272<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray">Mobile: +44 79 00 136 319<u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray"><a href="mailto:geraldine.clement-stoneham@headoffice.mrc.ac.uk" target="_blank"><span style="color:blue">geraldine.clement-stoneham@headoffice.mrc.ac.uk</span></a><u></u><u></u></span></p><p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray"> <u></u><u></u></span></p><p class="MsoNormal" align="right" style="text-align:right"><span style="font-size:9.0pt;font-family:&quot;Verdana&quot;,&quot;sans-serif&quot;;color:gray"><u></u> <u></u></span></p><p class="MsoNormal"><u></u> <u></u></p></div><br clear="both">
This email may have a protective marking, for an explanation please see <a href="http://www.mrc.ac.uk/About/Informationandstandards/Documentmarking/index.htm" target="_blank">http://www.mrc.ac.uk/About/Informationandstandards/Documentmarking/index.htm</a><br>
<br>
We use an electronic filing system. Please send electronic versions of documents, unless paper is specifically requested.<br>
_____________________________________________________________________<br>
This email has been scanned by the Symantec Email Security.cloud service.<br>
For more information please visit <a href="http://www.symanteccloud.com" target="_blank">http://www.symanteccloud.com</a><br>
______________________________________________________________________<br>
</div><br>_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" rel="noreferrer" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br></div></div></div>